See other companies on Welcome to the Jungle
myota
Gut health company creating ground breaking prebiotic products
- 1-20 employees
- B2C
- Personal health
- Wellbeing
- eCommerce
- Holborn, London, UK
Jump to section
Company mission
To prevent and reverse the 1 billion cases of chronic disease that exist globally.
75% female employees
Our take
Whilst research is still in its early stages, the benefits of good gut health are suspected to be substantial - and an increasing number of startups are being set up in this space.
myota is one of them, creating precision fibre mixes to help customers improve their gut microbiome. These can be ordered as subscriptions, aligning the company with the increasingly popular DTC subscription supplement model that’s springboarded the likes of Hims and Ro to success.
The approach chimes neatly with an increased consumer focus on at-home alternative health solutions, too. So it should come as no surprise that this previously uncharted territory has been flooded with new startups, and over $1B in VC cash. For a young startup, this level of investor appetite and support should prove encouraging.
On the flipside, many of these new startups (like Zoe, Floré, and Viome) offer at-home testing and subsequently personalised products. So whilst myota's UK market is less crowded with rivals than the US, the company may need to leverage this lead before it slips away.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- Unlimited holiday allowance
- Meaningful equity
- Free myota subscription
- Ability to work from anywhere in the world for up to 2 months of the year
- Central London office space in vibrant start-up community
- Whatever tech/tools you need to do your job
Funding (1 round)
Apr 2022
$0.8m
SEED
Total funding: $0.8m
Leadership
Thomas Gurry
(CEO)A computational biologist by training, Thomas is one of the world's leading experts on the gut microbiome. Thomas completed his PhD and post-doc at MIT, with additional stints at Cambridge & Imperial.
Katherine Stennett
(CCO)Experienced commercial leader who has been responsible for scaling teams & business from Seed to Series D across insurance and healthcare industries.
Articles
